XML 41 R26.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Consolidation of Variable Interest Entity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2015
Equity Method Investments And Joint Ventures [Abstract] |
Pro Forma Financial Information (Unaudited) | Pro Forma Financial Information (Unaudited). The financial information in the table below summarizes the combined results of operations of Milestone Scientific and subsidiaries and Milestone Medical Inc. (a variable interest entity) on a pro forma basis as though the companies had been combined as of the beginning of the earliest period presented. The pro forma financial information is presented for informational purposes only and is not indicative of the result of operations that would have been achieved if the consolidation had taken place at the beginning of each of the period presented.
| 2015 Pro Forma Consolidated |  |  | 2014 Pro Forma Consolidated |
Revenue | $ | 9,542,544 |  |  | $ | 10,333,089 |
Cost of sales |  | 3,061,299 |  |  |  | 3,630,765 |
Gross profit |  | 6,481,245 |  |  |  | 6,702,324 |
Selling, general and administrative expenses |  | 12,645,445 |  |  |  | 8,899,447 |
Research and development expenses |  | 892,255 |  |  |  | 489,551 |
Total operating expenses |  | 13,537,700 |  |  |  | 9,388,998 |
Loss income from operations |  | (7,056,455 | ) |  |  | (2,686,674 | )
Other Expenses |  | (5,347 | ) |  |  | - |
Interest Expense |  | (40,331 | ) |  |  | (2,955 | )
Interest Income |  | 3,838 |  |  |  | 5,057 |
Loss before provision for income taxes |  | (7,098,295 | ) |  |  | (2,684,572 | )
Provision for income tax |  | (36,157 | ) |  |  | (9,509 | )
Loss before equity in net earnings of equity investments |  | (7,134,452 | ) |  |  | (2,694,081 | )
Loss on earnings from Education Joint Venture |  | (7,846 | ) |  |  | (17,890 | )
Loss on earnings from China Joint Venture |  | (418,432 | ) |  |  | (810 | )
Net loss in equity investments |  | (426,278 | ) |  |  | (18,700 | )
Net loss |  | (7,560,730 | ) |  |  | (2,712,781 | )
Net loss attributable to the noncontrolling interests |  | 2,093,208 |  |  |  | 954,423 |
Net loss attributable to Milestone Scientific Inc. | $ | (5,467,522 | ) |  | $ | (1,758,358 | )

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration